Picture of SynAct Pharma AB logo

SYNACT SynAct Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: SynAct Pharma Announces Outcome In The Exercise Of Warrants

July 27 (Reuters) - SynAct Pharma AB  SYNACT.TE :
    * SYNACT PHARMA ANNOUNCES OUTCOME IN THE EXERCISE OF
WARRANTS,
WILL RECEIVE APPROXIMATELY MSEK 32.4
    * IS PROVIDED WITH A TOTAL OF APPROXIMATELY MSEK 32.4 BEFORE
ISSUE
COSTS
    * WITH ISSUE PROCEEDS CO HAS SECURED CAPITAL NEEDED TO
FINANCE
SEVERAL IMPORTANT MILESTONES, SUCH AS DEMONSTRATING
PROOF-OF-CONCEPT FOR PHASE II STUDIES WITH AP1189 WITHIN RA AND
NS

Source text for Eikon:  ID:nWkr1Q12n2 
Further company coverage:  SYNACT.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on SynAct Pharma AB

See all news